Adjuvant imatinib in high-risk resected gastrointestinal stromal tumors: Merely delaying the inevitable? - Sutton TL; Billingsley KG; Johnson AJ; Corless CL; Blanke CD; Heinrich MC; Mayo SC (Journal of surgical oncology, 2024)